Karyopharm Therapeutics revenue

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Karyopharm Therapeutics revenue was $108.09 m in FY, 2020

	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2018	FY, 2019	FY, 2020
Revenue	$387 k	$229 k	$250 k	$154 k	$30.34 m	$40.89 m	$108.09 m
Growth		(40.83%)	9.17%

	Q1, 2014	Q2, 2014	Q3, 2014	Q2, 2015	Q3, 2015	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2018	Q3, 2018	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021
Revenue	$171 k	$21 k	$21 k	$150 k	$75 k	$59 k	$48 k	$68 k	$19.89 m	$239 k	$155 k	$9.49 m	$13.15 m	$18.14 m	$33.51 m	$21.33 m	$23.26 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.